Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

[1]  K. Carlsen,et al.  Dietary prevention of allergic diseases in infants and small children , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[2]  Asher,et al.  The International Study of Asthma and Allergies in Childhood (ISAAC) , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  U. Wahn,et al.  Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial , 2006, BMJ : British Medical Journal.

[4]  M. Flaig,et al.  Cathelicidin deficiency predisposes to eczema herpeticum. , 2006, The Journal of allergy and clinical immunology.

[5]  M. Steinhoff,et al.  IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[6]  B. Harder,et al.  IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.

[7]  M. Worm,et al.  Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study , 2006, Allergy.

[8]  M. Cork,et al.  Safety and Tolerability of 1% Pimecrolimus Cream Among Infants: Experience With 1133 Patients Treated for Up to 2 Years , 2006, Pediatrics.

[9]  P. Schmid‐Grendelmeier,et al.  The role of sensitization to Malassezia sympodialis in atopic eczema. , 2006, Chemical immunology and allergy.

[10]  R. Foelster-Holst,et al.  Efficacy of Crisis Intervention Treatment with Topical Corticosteroid Prednicarbat with and without Partial Wet-Wrap Dressing in Atopic Dermatitis , 2005, Dermatology.

[11]  T. Chatila.  Role of regulatory T cells in human diseases. , 2005, The Journal of allergy and clinical immunology.

[12]  T. Chatila,et al.  Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. , 2005, The Journal of allergy and clinical immunology.

[13]  K. Turjanmaa.  The role of atopy patch tests in the diagnosis of allergy in atopic dermatitis , 2005, Current opinion in allergy and clinical immunology.

[14]  R. Holle,et al.  Association study of mast cell chymase polymorphisms with atopy , 2005, Allergy.

[15]  B. Niggemann,et al.  The cradle of IgE autoreactivity in atopic eczema lies in early infancy. , 2005, The Journal of allergy and clinical immunology.

[16]  S. Ziegler,et al.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.

[17]  S. Friedlander,et al.  Etanercept is minimally effective in 2 children with atopic dermatitis. , 2005, Journal of the American Academy of Dermatology.

[18]  W. Vach,et al.  A comparison between criteria for diagnosing atopic eczema in infants , 2005, British Journal of Dermatology.

[19]  A. Kapp,et al.  Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis , 2005, Dermatology.

[20]  N. Klopp,et al.  Association of NOD1 polymorphisms with atopic eczema and related phenotypes. , 2005, The Journal of allergy and clinical immunology.

[21]  K. Sayama,et al.  New mechanisms of skin innate immunity: ASK1‐mediated keratinocyte differentiation regulates the expression of β‐defensins, LL37, and TLR2 , 2005, European journal of immunology.

[22]  S. Nakaike,et al.  Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. , 2005, European journal of pharmacology.

[23]  W. Hoetzenecker,et al.  Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. , 2005, The Journal of allergy and clinical immunology.

[24]  H. Renz,et al.  Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. , 2005, The Journal of allergy and clinical immunology.

[25]  J. Epplen,et al.  The genetics of atopic dermatitis: recent findings and future options , 2005, Journal of Molecular Medicine.

[26]  J. Ring,et al.  Position paper on diagnosis and treatment of atopic dermatitis , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  P. Schmid‐Grendelmeier,et al.  IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. , 2005, The Journal of allergy and clinical immunology.

[28]  H. Sampson,et al.  Food allergy – accurately identifying clinical reactivity , 2005, Allergy.

[29]  E. Özkaya.  Adult-onset atopic dermatitis , 2005 .

[30]  R. Fimmers,et al.  Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. , 2005, The Journal of allergy and clinical immunology.

[31]  C. Wild,et al.  Risk factors for atopic dermatitis in New Zealand children at 3·5 years of age , 2005, The British journal of dermatology.

[32]  G. Schuler,et al.  Infliximab in the treatment of moderate to severe atopic dermatitis. , 2005, Journal of the American Academy of Dermatology.

[33]  T. Schäfer.  [Prevention of atopic eczema. Evidence based guidelines]. , 2005, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[34]  B. Niggemann,et al.  The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  H. Williams,et al.  Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[36]  Grant Okawa,et al.  Evidence-based guidelines. , 2005, The Permanente journal.

[37]  T. Werfel,et al.  Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic Dermatitis , 2005, American journal of clinical dermatology.

[38]  J. Ring,et al.  The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study , 2004, Allergy.

[39]  C. Akdis,et al.  Apoptosis in tissue inflammation and allergic disease. , 2004, Current opinion in immunology.

[40]  N. Reynolds,et al.  Guidelines for prescribing azathioprine in dermatology , 2004, The British journal of dermatology.

[41]  T. Werfel,et al.  Role of food allergy in atopic dermatitis , 2004, Current opinion in allergy and clinical immunology.

[42]  T. Schäfer.  [Prevention of atopic eczema]. , 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[43]  E. Carter,et al.  A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. , 2004, Journal of the American Academy of Dermatology.

[44]  P. Hoeger.  Antimicrobial susceptibility of skin‐colonizing S. aureus strains in children with atopic dermatitis , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[45]  T. Schäfer,et al.  Prävention des atopischen Ekzems , 2004, Der Hautarzt.

[46]  Z. Tran,et al.  Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.

[47]  K. Carlsen,et al.  Dietary prevention of allergic diseases in infants and small children , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[48]  T. Bieber,et al.  Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.

[49]  A. Boner,et al.  Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: avoidance of indoor allergens , 2004, Allergy.

[50]  H. Williams,et al.  Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. , 2004, The Journal of investigative dermatology.

[51]  Scott R. Presnell,et al.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.

[52]  K. Nékám,et al.  Standardization of food challenges in patients with immediate reactions to foods – position paper from the European Academy of Allergology and Clinical Immunology , 2004, Allergy.

[53]  C. Akdis,et al.  Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells , 2004, The Journal of experimental medicine.

[54]  S. Halken,et al.  Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[55]  K. Carlsen,et al.  Dietary prevention of allergic diseases in infants and small children. , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[56]  H. Simon,et al.  Eosinophils and atopic dermatitis , 2004, Allergy.

[57]  E. Kownatzki,et al.  Corneometric, sebumetric and TEWL measurements following the cleaning of atopic skin with a urea emulsion versus a detergent cleanser , 2004, Contact dermatitis.

[58]  Hugh A Sampson,et al.  Update on food allergy. , 2004, The Journal of allergy and clinical immunology.

[59]  H. Wichmann,et al.  Effect of breast-feeding on the development of atopic dermatitis during the first 3 years of life--results from the GINI-birth cohort study. , 2004, The Journal of pediatrics.

[60]  A. Heratizadeh,et al.  Late eczematous reactions to food in children with atopic dermatitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[61]  B. Niggemann,et al.  The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. , 2004, The Journal of allergy and clinical immunology.

[62]  T. Bieber,et al.  FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. , 2004, The Journal of allergy and clinical immunology.

[63]  Shinichi Sato,et al.  Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. , 2004, The Journal of allergy and clinical immunology.

[64]  T. Platts-Mills,et al.  T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis. , 2004, The Journal of investigative dermatology.

[65]  L. Ou,et al.  T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. , 2004, The Journal of allergy and clinical immunology.

[66]  K. Peeters,et al.  Resistance of Staphylococcus aureus to fusidic acid , 2004, International journal of dermatology.

[67]  Donald Y M Leung,et al.  Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .

[68]  D. Margolis,et al.  Guidelines of care for atopic dermatitis , 2004 .

[69]  M. D. de Bruin‐Weller,et al.  Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.

[70]  Q. Jöbsis,et al.  Exhaled breath condensate in children: Pearls and pitfalls , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[71]  K. Subramanyan.  Role of mild cleansing in the management of patient skin , 2004, Dermatologic therapy.

[72]  A. Patrizi,et al.  Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis , 2004, The British journal of dermatology.

[73]  H. Maibach,et al.  Stratum Corneum pH in Atopic Dermatitis , 2004 .

[74]  F. Mastrandrea.  The Potential Role of Allergen-Specific Sublingual Immunotherapy in Atopic Dermatitis , 2004, American journal of clinical dermatology.

[75]  R. Dahl,et al.  Atopic dermatitis -- a total genome-scan for susceptibility genes. , 2004, Acta dermato-venereologica.

[76]  T. Bieber,et al.  Immune mechanisms leading to atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[77]  S. Tinkle,et al.  Risks of smallpox vaccination: 200 years after Jenner. , 2003, The Journal of allergy and clinical immunology.

[78]  T. Kupper,et al.  Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. , 2003, The Journal of clinical investigation.

[79]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[80]  D. Umetsu,et al.  Regulatory T cells control the development of allergic disease and asthma. , 2003, The Journal of allergy and clinical immunology.

[81]  D. Leung.  Infection in atopic dermatitis , 2003, Current opinion in pediatrics.

[82]  G. Plewig,et al.  Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. , 2003, Journal of the American Academy of Dermatology.

[83]  T. Bieber,et al.  Allergic and nonallergic forms of atopic diseases. , 2003, The Journal of allergy and clinical immunology.

[84]  J. Ring,et al.  Silver-Coated Textiles Reduce Staphylococcus aureus Colonization in Patients with Atopic Eczema , 2003, Dermatology.

[85]  C. Akdis,et al.  A Second Step of Chemotaxis After Transendothelial Migration: Keratinocytes Undergoing Apoptosis Release IFN-γ-Inducible Protein 10, Monokine Induced by IFN-γ, and IFN-γ-Inducible α-Chemoattractant for T Cell Chemotaxis Toward Epidermis in Atopic Dermatitis1 , 2003, The Journal of Immunology.

[86]  C. Bindslev‐Jensen,et al.  Threshold levels in food challenge and specific IgE in patients with egg allergy: is there a relationship? , 2003, The Journal of allergy and clinical immunology.

[87]  T. Bieber,et al.  Allergic hyperreactivity to microbial components: a trigger factor of "intrinsic" atopic dermatitis? , 2003, The Journal of allergy and clinical immunology.

[88]  U. Jappe,et al.  Frequency of sensitization to antimicrobials in patients with atopic eczema compared with nonatopic individuals: analysis of multicentre surveillance data, 1995–1999 , 2003, The British journal of dermatology.

[89]  R. Damstra,et al.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.

[90]  A. Nikkels,et al.  Framing the Future of Antifungals in Atopic Dermatitis , 2003, Dermatology.

[91]  C. Akdis,et al.  T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[92]  J. Cove,et al.  Short‐term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema , 2003, British Journal of Dermatology.

[93]  V. Deleo,et al.  Phototherapy of atopic dermatitis. , 2003, Clinics in dermatology.

[94]  Donald Rudikoff,et al.  The treatment of atopic dermatitis with systemic immunosuppressive agents. , 2003, Clinics in dermatology.

[95]  J. Saurat,et al.  International Consensus Conference on Atopic Dermatitis II (ICCAD II * ): clinical update and current treatment strategies , 2003, The British journal of dermatology.

[96]  Thomas Bieber,et al.  Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donors , 2003 .

[97]  A. Wollenberg,et al.  Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[98]  Q. Hamid,et al.  Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. , 2003, The Journal of allergy and clinical immunology.

[99]  K. Northstone,et al.  FOOD ALLERGY FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PEANUT ALLERGY IN CHILDHOOD , 2004 .

[100]  H. Wichmann,et al.  The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. , 2003, The Journal of allergy and clinical immunology.

[101]  H. Hönigsmann,et al.  Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[102]  M. Lóden.  Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders , 2003, American journal of clinical dermatology.

[103]  J. Lübbe.  Secondary Infections in Patients with Atopic Dermatitis , 2003, American journal of clinical dermatology.

[104]  U. Darsow,et al.  Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients. , 2003, The Journal of allergy and clinical immunology.

[105]  G. Hartmann,et al.  Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. , 2002, The Journal of investigative dermatology.

[106]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[107]  G. Imokawa,et al.  Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. , 2002, The Journal of investigative dermatology.

[108]  J. Berth-Jones,et al.  Azathioprine in severe adult atopic dermatitis: a double‐blind, placebo‐controlled, crossover trial , 2002, The British journal of dermatology.

[109]  T. Diepgen.  Long‐term treatment with cetirizine of infants with atopic dermatitis: A multi‐country, double‐blind, randomized, placebo‐controlled trial (the ETAC™ trial) over 18 months , 2002 .

[110]  F. Wojnarowska,et al.  Guidelines for the management of bullous pemphigoid , 2002, The British journal of dermatology.

[111]  T. Makino,et al.  Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis , 2002, The British journal of dermatology.

[112]  S. Häussler,et al.  Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis , 2002, The British journal of dermatology.

[113]  U. Wahn,et al.  Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. , 2002, Pediatrics.

[114]  I. Kockum,et al.  Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. , 2002, Human molecular genetics.

[115]  M. Boguniewicz,et al.  Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. , 2002, Journal of the American Academy of Dermatology.

[116]  H. Williams,et al.  Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema , 2002, BMJ : British Medical Journal.

[117]  D. Chinn,et al.  Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. , 2002, The British journal of dermatology.

[118]  M. Gdalevich,et al.  Does breastfeeding protect against allergic rhinitis during childhood? A meta‐analysis of prospective studies , 2002, Acta paediatrica.

[119]  A. Scheynius,et al.  Atopic Eczema/Dermatitis Syndrome and Malassezia , 2002, International Archives of Allergy and Immunology.

[120]  M. Boguniewicz,et al.  Conventional therapy for atopic dermatitis , 2002 .

[121]  J. Warner,et al.  A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. , 2001, The Journal of allergy and clinical immunology.

[122]  C. Akdis,et al.  Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. , 2001, The Journal of allergy and clinical immunology.

[123]  T. Werfel,et al.  Bacterial infections and atopic dermatitis , 2001, Allergy.

[124]  Luting Xu,et al.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. , 2001, The Journal of investigative dermatology.

[125]  M. Boguniewicz,et al.  Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. , 2001, The Journal of allergy and clinical immunology.

[126]  C. Akdis,et al.  The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. , 2001, The Journal of investigative dermatology.

[127]  C. Akdis,et al.  Epidemiology, clinical features, and immunology of the “intrinsic” (non‐IgE‐mediated) type of atopic dermatitis (constitutional dermatitis) , 2001, Allergy.

[128]  N. Reynolds,et al.  Azathioprine for atopic dermatitis , 2001, Clinical and experimental dermatology.

[129]  B. Diffey,et al.  Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial , 2001, The Lancet.

[130]  A. Fischer,et al.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. , 2001, The New England journal of medicine.

[131]  N. Cox,et al.  British Association of Dermatologists , 2001 .

[132]  O. Kortekangas-Savolainen,et al.  Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE‐mediated hypersensitivity to yeasts , 2001, Allergy.

[133]  A. Giannetti,et al.  Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. , 2001, The Journal of allergy and clinical immunology.

[134]  H. Sampson.  Utility of food-specific IgE concentrations in predicting symptomatic food allergy. , 2001, The Journal of allergy and clinical immunology.

[135]  E. Novembre,et al.  Natural history of “intrinsic” atopic dermatitis , 2001, Allergy.

[136]  A. Knulst,et al.  SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis , 2001, The British journal of dermatology.

[137]  J. Harper,et al.  First experience of topical SDZ ASM 981 in children with atopic dermatitis , 2001, The British journal of dermatology.

[138]  G. Abecasis,et al.  Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci , 2001, Nature Genetics.

[139]  J. Ortonne,et al.  The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double‐blind controlled study , 2001, The British journal of dermatology.

[140]  D. Leung,et al.  Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? , 2001, The Journal of allergy and clinical immunology.

[141]  J. Bartosik,et al.  Systemic ketoconazole for yeast allergic patients with atopic dermatitis , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[142]  T. Werfel,et al.  Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. , 2001, The Journal of allergy and clinical immunology.

[143]  M. Pembrey,et al.  ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. , 2001, Paediatric and perinatal epidemiology.

[144]  U. Wahn,et al.  The Impact of Childhood Atopic Dermatitis on Quality of Life of the Family , 2000, Dermatology and Psychosomatics / Dermatologie und Psychosomatik.

[145]  T. Wienker,et al.  A major susceptibility locus for atopic dermatitis maps to chromosome 3q21 , 2000, Nature Genetics.

[146]  S. Salminen,et al.  Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[147]  S. Halken,et al.  Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention:A prospective, randomized study , 2000, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[148]  J. Ravenscroft,et al.  Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK , 2000, Clinical and experimental dermatology.

[149]  S. Muro,et al.  Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. , 2000, The Journal of allergy and clinical immunology.

[150]  D. Gustafsson,et al.  Development of allergies and asthma in infants and young children with atopic dermatitis – a prospective follow‐up to 7 years of age , 2000, Allergy.

[151]  J. Ring,et al.  Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. , 2000, Journal of the American Academy of Dermatology.

[152]  C. Akdis,et al.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. , 2000, The Journal of clinical investigation.

[153]  R. Valenta,et al.  Autoallergy: a pathogenetic factor in atopic dermatitis? , 2000, Current problems in dermatology.

[154]  M. Wjst,et al.  Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. , 1999, The Journal of allergy and clinical immunology.

[155]  T. Platts-Mills,et al.  Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. , 1999, The Journal of allergy and clinical immunology.

[156]  P. Klein,et al.  An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. , 1999, Archives of dermatology.

[157]  D. van der Meer,et al.  The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate , 1999, The British journal of dermatology.

[158]  J. Faergemann.  Pityrosporum species as a cause of allergy and infection , 1999, Allergy.

[159]  R. Geha,et al.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. , 1999, The Journal of clinical investigation.

[160]  A. Wolkerstorfer,et al.  Treatment of erythrodermic atopic dermatitis with “wet-wrap” fluticasone propionate 0.05% cream/emollient 1:1 dressings , 1999 .

[161]  Abeck,et al.  Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications , 1998, The British journal of dermatology.

[162]  Williams,et al.  The natural history of childhood eczema: observations from the British 1958 birth cohort study , 1998, The British journal of dermatology.

[163]  P. Hufnagl,et al.  Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[164]  L. Patel,et al.  Side to side comparison of topical treatment in atopic dermatitis , 1998, Archives of disease in childhood.

[165]  T. Ruzicka,et al.  Human eosinophils produce biologically active IL-12: implications for control of T cell responses. , 1998, Journal of immunology.

[166]  Richard Beasley,et al.  Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC , 1998, The Lancet.

[167]  R. Geha,et al.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. , 1998, The Journal of clinical investigation.

[168]  G. Girolomoni,et al.  Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis☆☆☆★★★ , 1998 .

[169]  T. Luger,et al.  High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. , 1998, Journal of the American Academy of Dermatology.

[170]  B. Cohen,et al.  Prevalence of IgE-Mediated Food Allergy Among Children With Atopic Dermatitis , 1998, Pediatrics.

[171]  B. Wedi,et al.  Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. , 1997, The Journal of allergy and clinical immunology.

[172]  A. Kemp,et al.  Topical triclosan treatment of atopic dermatitis. , 1997, The Journal of allergy and clinical immunology.

[173]  D. Gawkrodger,et al.  Azathioprine in dermatology: a survey of current practice in the U.K. , 1997, The British journal of dermatology.

[174]  J. English,et al.  Long‐term efficacy and safety of cyclosporin in severe adult atopic dermatitis , 1997, The British journal of dermatology.

[175]  J. English,et al.  Retrospective review of the use of azathioprine in severe atopic dermatitis. , 1996, Journal of the American Academy of Dermatology.

[176]  I. Zaki,et al.  Treatment of severe atopic dermatitis in childhood with cyclosporin , 1996, The British journal of dermatology.

[177]  P. A. Leonard,et al.  Triclosan: applications and safety. , 1996, American journal of infection control.

[178]  A. Finlay,et al.  Cyclosporine in severe childhood atopic dermatitis: a multicenter study. , 1996, Journal of the American Academy of Dermatology.

[179]  I. Strickland,et al.  Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis , 1996, The Lancet.

[180]  S. Seidenari,et al.  Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. , 1995, Acta dermato-venereologica.

[181]  M. Kerscher,et al.  In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. , 1995, International journal of clinical pharmacology and therapeutics.

[182]  H. Williams,et al.  Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. , 1995, BMJ.

[183]  L. Gibson,et al.  The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. , 1995, Archives of dermatology.

[184]  Q. Hamid,et al.  Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. , 1995, The Journal of clinical investigation.

[185]  J. Stalder,et al.  Local steroid therapy and bacterial skin flora in atopic dermatitis , 1994, The British journal of dermatology.

[186]  H. Degreef,et al.  Atopic dermatitis: triggering factors. , 1994, Journal of the American Academy of Dermatology.

[187]  Q. Hamid,et al.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.

[188]  S. Powell,et al.  'Wet-wrap' dressings for the treatment of atopic eczema in the community , 1994 .

[189]  D. Gawkrodger,et al.  The prevalence of childhood atopic eczema in a general population. , 1994, Journal of the American Academy of Dermatology.

[190]  H. Sampson,et al.  Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.

[191]  A. Kapp,et al.  The role of eosinophils in the pathogenesis of atopic dermatitis ‐ eosinophil granule proteins as markers of disease activity , 1993, Allergy.

[192]  E. Nilsson,et al.  Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. , 1992, Journal of the American Academy of Dermatology.

[193]  M. Kerscher,et al.  Topical glucocorticoids with improved benefit/risk ratio: do they exist? , 1992, Journal of the American Academy of Dermatology.

[194]  M. Preece,et al.  The treatment of difficult atopic dermatitis in childhood with oral beclomethasone dipropionate. , 1992, Acta dermato-venereologica. Supplementum.

[195]  A. Y. Finlay,et al.  Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis , 1991, The Lancet.

[196]  R. Bergström,et al.  The antipruritic effect of a sedative and a non‐sedative antihistamine in atopic dermatitis , 1990, The British journal of dermatology.

[197]  B. Davies,et al.  Treatment of Bramhamella catarrhalis infections , 1990 .

[198]  G. Swanbeck,et al.  Parental education in the treatment of childhood atopic eczema. , 1990, Acta dermato-venereologica.

[199]  L. Verbist,et al.  The antimicrobial activity of fusidic acid. , 1990, The Journal of antimicrobial chemotherapy.

[200]  C. Koblenzer,et al.  Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: improvement through parent insight and education. , 1988, Archives of dermatology.

[201]  Jose Mc Skimming,et al.  A PILOT STUDY OF A SUPPORT GROUP FOR PARENTS OF CHILDREN WITH ECZEMA , 1984, The Australasian journal of dermatology.

[202]  M. Chapman,et al.  The role of dust mite allergens in atopic dermatitis , 1983, Clinical and experimental dermatology.

[203]  R. Geha,et al.  Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. , 1983, The Journal of allergy and clinical immunology.

[204]  M. Chapman,et al.  BASOPHILS IN ALLERGEN-INDUCED PATCH TEST SITES IN ATOPIC DERMATITIS , 1982, The Lancet.

[205]  J. Leyden,et al.  The case for steroid—antibiotic combinations , 1977, The British journal of dermatology.